AEON Biopharma, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q3 2023 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
-
Summary
-
AEON Biopharma, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q3 2023 to Q2 2024.
- AEON Biopharma, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending June 30, 2024 was $188K.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)